Today: 9 April 2026
Tesla stock jumps late week as China AI-training report hits tape; TSLA slips after hours
6 February 2026
2 mins read

Tesla stock jumps late week as China AI-training report hits tape; TSLA slips after hours

New York, Feb 6, 2026, 16:16 ET — After-hours

  • Tesla shares rose about 3.5% at the close; the stock ticked lower in after-hours trade
  • A China report said Tesla has set up an AI training centre aimed at local assisted-driving work
  • Investors are watching delayed U.S. jobs and inflation data next week for the next push in growth stocks

Tesla Inc (TSLA.O) shares closed up 3.5% at $411.02 on Friday and were down 0.2% at $410.10 in after-hours trading. The stock swung between $397.75 and $414.55 during the session. StockAnalysis

The move came after a China report said Tesla has set up an artificial intelligence training centre in the country to train its AI technology for assisted driving, citing Tesla vice president Tao Lin. Assisted driving — often called advanced driver assistance (ADAS) — can help with steering and braking but still requires a driver. Reuters

Why it matters now: Tesla’s share price is tied to the idea that software and autonomy can do more of the heavy lifting than car sales. At the same time, the broader “AI build-out” trade has turned jumpy as investors question how quickly huge spending pays off, even as the Nasdaq and S&P 500 rebounded on Friday. “It’s a de-risking trade,” said Andrew Wells, chief investment officer at SanJac Alpha. Reuters

China has also been a live wire for Tesla’s demand story. Data from the China Passenger Car Association showed sales of China-made Model 3 and Model Y vehicles, including exports, rose 9.3% in January from a year earlier, while Tesla’s China market share in 2025 fell to 8% from 10% in 2024, the data showed. CEO Elon Musk has said he expects regulators in Europe and China to approve Tesla’s driver-supervised Full Self-Driving (FSD) system as early as this month. Reuters

Europe is going the other way on the scoreboard. Volkswagen’s core brand overtook Tesla in battery-electric vehicle sales in Europe in 2025, JATO Dynamics data showed, with Tesla registrations down 27% as rivals pushed new models and cheaper trims. “Tesla’s success may start to be a thing of the past,” JATO global analyst Felipe Munoz said. Reuters

In Britain, the numbers were blunt. Tesla sales fell 57.3% year-on-year in January to 647 cars, data from New Automotive showed, even as overall UK battery-electric sales jumped more than 40%. “British consumers are still moving towards cars with plugs, and away from those without,” said Tanya Sinclair, chief executive at Electric Vehicles UK. Reuters

Policy risk is still part of the autonomy wager. In Washington this week, lawmakers, Waymo and Tesla urged Congress to move on long-stalled legislation meant to speed deployment of self-driving vehicles — including robotaxis, cars meant to drive themselves as paid ride-hailing — warning the U.S. is falling behind China. Tesla vehicle engineering vice president Lars Moravy said Congress “must modernize regulations that inhibit industry’s ability to innovate.” Reuters

But the downside case is not hard to sketch. Tesla is dealing with choppy demand signals in Europe and the UK, and it faces legal and regulatory questions as it markets autonomy more aggressively. A U.S. judge this week said he was inclined to let a “Blade Runner 2049” copyright suit against Tesla and Musk proceed over allegations they used AI-generated images mimicking the film to promote the “cybercab.” Reuters

For traders, the next catalyst is macro, not a new Model Y trim. The Labor Department has rescheduled January’s U.S. employment report to Wednesday, Feb. 11, and the January consumer price index report to Friday, Feb. 13, after a federal government shutdown delayed releases, the Bureau of Labor Statistics said. Reuters

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Micron stock swings after Nvidia HBM4 doubts clash with a bullish UBS call
Previous Story

Micron stock swings after Nvidia HBM4 doubts clash with a bullish UBS call

Amazon stock slides after $200 billion AI spending plan puts returns in the spotlight
Next Story

Amazon stock slides after $200 billion AI spending plan puts returns in the spotlight

Go toTop